Arcellx Company
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Technology:
CAR-T
Industry:
CAR-T
Headquarters:
Gaithersburg, Maryland, United States
Founded Date:
2015-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
18
Total Funding:
29925605
Estimated Revenue:
$10M to $50M
Last Funding Date:
2022-06-15
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership